ANTIMICROBIAL CHEMOTHERAPY FOR LEGIONNAIRES-DISEASE - A REVIEW

Authors
Citation
Ph. Edelstein, ANTIMICROBIAL CHEMOTHERAPY FOR LEGIONNAIRES-DISEASE - A REVIEW, Clinical infectious diseases, 21, 1995, pp. 265-276
Citations number
157
Categorie Soggetti
Microbiology,Immunology,"Infectious Diseases
ISSN journal
10584838
Volume
21
Year of publication
1995
Supplement
3
Pages
265 - 276
Database
ISI
SICI code
1058-4838(1995)21:<265:ACFL-A>2.0.ZU;2-G
Abstract
Controlled trials of antimicrobial chemotherapy for legionnaires' dise ase have not been performed, although erythromycin and tetracycline ap pear to be effective therapies. Laboratory data indicate that the acti vities of the fluoroquinolone and newer macrolide/azalide agents again st Legionella pneumophila are superior to that of erythromycin, and ca se reports substantiate that the activities of these agents are at lea st equal. Results of clinical treatment with and laboratory testing of macrolides, tetracyclines, co-trimoxazole, chloramphenicol, aminoglyc osides, fluoroquinolones, beta-lactam agents, and streptogramins are r eviewed. The drugs of choice for the treatment of legionnaires' diseas e in immunocompromised or severely ill patients should be one of the f luoroquinolone antimicrobials rather than erythromycin.